Stereotactic Ablative Radiotherapy: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Stereotactic Ablative Radiotherapy

• Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
  NCT06325046 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 5 locations
• Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
  NCT06084338 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 4 locations
• Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
  NCT06563388 · Phase: Phase 3 · Ages: 1 Year and older · Sex: All (male and female) · 2 locations
• Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia
  NCT05696522 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
  NCT05673148 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 187 locations

Common questions

How many recruiting trials involve Stereotactic Ablative Radiotherapy?

5 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.